Kabra Drugs
24.91
+0.14(+0.57%)
Market Cap₹59.03 Cr
PE Ratio13.69
IndustryHealthcare
Company Performance:
1D+0.57%
1M-3.37%
6M+33.49%
1Y+124.82%
5Y+522.75%
View Company Insightsright
More news about Kabra Drugs
01Jan 26
Kabra Drugs Board Approves Strategic Acquisitions and Business Diversification
Kabra Drugs Limited successfully concluded its January 1, 2026 board meeting with approval of transformative strategic initiatives including the acquisition of Vassmaan Automotive PVT LTD for medical equipment and EV components manufacturing, expansion of distribution network through 200 channel partners nationwide, company name change, and MOA amendments to diversify into electric vehicle components, steel manufacturing, and solar energy sectors, with all decisions subject to shareholder approval through an upcoming EGM.
 no imag found
14Nov 25
Kabra Drugs Limited Reports Profit Turnaround in Q2 FY2026
Kabra Drugs Limited announced financial results for Q2 FY2026, reporting a revenue of ₹1,976.40 lakhs and a net profit of ₹183.68 lakhs. This marks a significant turnaround from the previous quarter's loss. The company's basic earnings per share for the quarter was ₹0.77. The Board of Directors approved these unaudited financial statements on November 13, 2025. The company also disclosed its Board composition and reconstituted various committees as part of its corporate governance practices.
 no imag found
24Sept 25
Kabra Drugs to Finalize Acquisition of AMR Pharma India in Upcoming Board Meeting
Kabra Drugs Limited has scheduled a board meeting for October 8, 2025, to discuss key strategic moves. The agenda includes approving the Share Purchase Agreement for acquiring AMR PHARMA INDIA PRIVATE LIMITED, expanding the board with new technical personnel, and authorizing steps to execute the acquisition transaction. This meeting signals potential growth and enhanced expertise for the pharmaceutical company.
 no imag found
06Aug 25
Kabra Drugs Limited Diversifies into Medical Equipment, Establishes Chennai Office
Kabra Drugs Limited's Board of Directors has approved diversification into the medical equipment and medical instruments sector. The company will establish a new office in Chennai at Cactus Corporate Coworking, Tecci Park, to support this venture. The decision was made during a board meeting on August 6, 2025, from 6:00 PM to 7:00 PM (IST). This move represents a significant expansion of Kabra Drugs' business operations beyond pharmaceuticals.
 no imag found
Kabra Drugs
24.91
+0.14
(+0.57%)
1 Year Returns:+124.82%
Industry Peers
Sun Pharmaceutical
1,747.30
(+0.80%)
Divis Laboratories
6,432.50
(-0.69%)
Torrent Pharmaceuticals
4,182.90
(-0.87%)
Dr Reddys Laboratories
1,354.60
(+1.51%)
Cipla
1,306.50
(-0.81%)
Lupin
2,302.70
(-0.94%)
Mankind Pharma
2,264.40
(-0.19%)
Zydus Life Science
911.30
(-3.02%)
Aurobindo Pharma
1,422.60
(+0.42%)
Glenmark Pharmaceuticals
2,403.70
(+3.38%)